103 related articles for article (PubMed ID: 8352517)
1. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
Janvier G; Carles J
Ann Chir; 1993; 47(4):370-5. PubMed ID: 8352517
[TBL] [Abstract][Full Text] [Related]
2. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
Midy D; Pometan JP; Baste JC; Pajadon V
J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
[TBL] [Abstract][Full Text] [Related]
3. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F
Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
[TBL] [Abstract][Full Text] [Related]
5. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
Kuo BI; Fung CP; Liu CY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
[TBL] [Abstract][Full Text] [Related]
6. [Study of the intraperitoneal penetration of imipenem/cilastatin in acute peritonitis with perforation].
Pezé P; Mounier M; Cevallos R; Denis F
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):504-7. PubMed ID: 2385446
[TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S
Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
[TBL] [Abstract][Full Text] [Related]
8. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
Garbino J; Villiger P; Caviezel A; Matulionyte R; Uckay I; Morel P; Lew D
Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
10. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB
Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
Eckhauser FE; Knol JA; Raper SE; Mulholland MW; Helzerman P
Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Niinikoski J; Havia T; Alhava E; Pääkkönen M; Miettinen P; Kivilaakso E; Haapiainen R; Matikainen M; Laitinen S
Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of imipenem/cilastatin in the therapy of severe infections in high-risk patients.
Cristiano P
Drugs Exp Clin Res; 1989; 15(1):17-20. PubMed ID: 2743870
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
Levy E; Levy P
J Chir (Paris); 1993 Apr; 130(4):200-9. PubMed ID: 8345014
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
[TBL] [Abstract][Full Text] [Related]
16. Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
Merchant MR; Anwar N; Were A; Uttley L; Tooth JA; Gokal R
Adv Perit Dial; 1992; 8():234-7. PubMed ID: 1361795
[TBL] [Abstract][Full Text] [Related]
17. Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
Wilson SE; Faulkner K
Am Surg; 1998 May; 64(5):402-7. PubMed ID: 9585772
[TBL] [Abstract][Full Text] [Related]
18. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.
Zanetti G; Harbarth SJ; Trampuz A; Ganeo M; Mosimann F; Chautemps R; Morel P; Lew D; Zimmerli W; Lange J; Glauser M
Int J Antimicrob Agents; 1999 Feb; 11(2):107-13. PubMed ID: 10221413
[TBL] [Abstract][Full Text] [Related]
19. Neurological complication during imipenem/cilastatin therapy in uraemic patients.
Campise M
Nephrol Dial Transplant; 1998 Jul; 13(7):1895-6. PubMed ID: 9681765
[No Abstract] [Full Text] [Related]
20. Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
Kanellakopoulou K; Giamarellou H; Papadothomakos P; Tsipras H; Chloroyiannis J; Theakou R; Sfikakis P
Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):449-53. PubMed ID: 8359165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]